ReviewBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2024
[Gender-sensitive health indicators for health reporting at the Robert Koch Institute (GBE-GI)-a pilot project as part of the Joint Action PreventNCD project].
Review in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Health reporting (GBE) based on gender-sensitive indicators can provide information on gender inequalities, improve health promotion and healthcare, promote gender mainstreaming, and provide relevant information for gender equality measures. To date, there is no set of gender-sensitive health indicators for Federal Health Reporting at the Robert Koch Institute. As part of the Joint Action Prevent Non-Communicable Diseases, gender-sensitive health indicators are to be identified, evaluated, and integrated into the Robert Koch Institute's health reporting website in a pilot project. This is done in three work packages. In a scoping review, the available evidence on gender-sensitive health indicators and theoretical explanations for gender inequality in EU and OECD member states since 2014 will initially be assessed (work package 1). Building on this, identified indicators and explanatory approaches will be collated for evaluation and selection in a structured consensus process as part of a three-stage Delphi approach consisting of a focus group discussion and an online survey (work package 2). The evaluated indicator set will then be integrated into the Robert Koch Institute's health reporting website (work package 3). The results will be disseminated via scientific publications and conference presentations. An English full-text version of this article is available at SpingerLink as Supplementary Information.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.